Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Guangzhou Amino Up Health Food Science & Technology is a Chinese nutraceutical company that operates as a regional arm of the Japanese biotechnology firm Amino Up Co., Ltd. The company specializes in the research, development, and distribution of scientifically-validated functional ingredients derived from natural sources. Its core portfolio includes AHCC (Active Hexose Correlated Compound), a mycelia extract used for immune modulation, and Oligonol, a highly bioavailable polyphenol extract. The company focuses on providing evidence-based health solutions for immune support, liver health, and integrative oncology support within the Chinese market. It maintains a strong emphasis on clinical research, collaborating with various institutions to validate the efficacy of its natural compounds.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Guangzhou Amino Up Health Food Science & Technology.